Parvin Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-25
Closed -$948 – 356
2024
Q4
$948 Buy
+25
New +$998 ﹤0.01% 317

Other funds holding BME

Parvin Asset Management's BME Position: Q1 2025 in Review

Parvin Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q1 2025, closing a stake of 25 shares — an estimated $948 sold.

Parvin Asset Management first reported a position in BME in Q4 2024 and held it in 1 quarter. The position peaked at $948 in Q4 2024. 67 funds tracked by Wall St. Rank hold BME as of Q1 2025.

  • Parvin Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q1 2025 after selling out during the quarter.
  • Parvin Asset Management sold 25 BlackRock Health Sciences Trust shares in Q1 2025, an estimated $948.
  • Parvin Asset Management first reported a position in BlackRock Health Sciences Trust in Q4 2024 and held it in 1 quarter.
  • Parvin Asset Management's BlackRock Health Sciences Trust position peaked at $948 in Q4 2024.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2025.

Based on Parvin Asset Management's 13F filing for Q1 2025, filed 15 May 2025.